Calico Life Sciences
Alphabet-backed research into the biology of aging
Calico Life Sciences is a research and development company founded by Google/Alphabet with the mission of understanding the biology of aging and developing interventions to extend healthy human lifespan. The company operates as an independent Alphabet subsidiary with substantial long-term funding, pursuing fundamental research into aging mechanisms alongside a growing therapeutic pipeline.
Target Discovery, Platform
~5 programs in clinic, ~20 in preclinical development
Funding
Alphabet/Google · AbbVie
Technology
Combines fundamental biology research into aging mechanisms with computational and AI-driven drug discovery. Focuses on understanding the molecular pathways that control lifespan and healthspan, translating insights into therapeutics.
Leadership
Art Levinson
CEO & Founder
Former Chairman of Apple, former CEO of Genentech
Partnerships
Similar companies
BenevolentAI
AI-enabled knowledge graph for drug discovery and repurposing
clinical · 2014Bioptimus
Universal biology foundation model from ex-DeepMind team
platform · 2024Cellarity
Cell behavior-level drug discovery with single-cell AI
preclinical · 2019Enveda Biosciences
Unlocking nature's chemistry with ML for drug discovery
preclinical · 2019Get updates on Calico Life Sciences
We'll notify you when we publish updates about Calico Life Sciences.